Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death. (Q46024830)
Jump to navigation
Jump to search
scientific article published on 4 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death. |
scientific article published on 4 May 2009 |
Statements
1 reference
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death. (English)
1 reference
Michael Weller
1 reference
Wolfgang Wick
1 reference
Joachim P Steinbach
1 reference
Michael W Ronellenfitsch
1 reference
Felix Tritschler
1 reference
Daniel P Brucker
1 reference
Michael C Burger
1 reference
Stefan Wolking
1 reference
Johannes Rieger
1 reference
4 May 2009
1 reference
1 reference
132
1 reference
Pt 6
1 reference
1509-1522
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference